XIAO MA: Open Payments
NPI 1215396825 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 3 payments from 3 companies in 2025. Trend: 2023 $158 · 2024 $692 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Epclusa, ZERBAXA, ELIQUIS.
Industry payments across NY — which companies pay providers there.
